# Bruno Vincenzi

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/bruno-vincenzi/

## Facts

| Field | Value |
| --- | --- |
| Citations | 21,126 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 72 |
| i10-index | 338 |
| Last Known Institution | Università Campus Bio-Medico |
| OpenAlex ID | https://openalex.org/A5075514238 |
| ORCID iD | https://orcid.org/0000-0001-8222-9025 |
| Works | 939 |

## Researcher papers

- [Effects of KRAS, BRAF, NRAS, and PIK3CA mutations on the efficacy of cetuximab plus chemotherapy in chemotherapy-refractory metastatic colorectal cancer: a retrospective consortium analysis](https://scholariq.org/papers/effects-of-kras-braf-nras-and-pik3ca-mutations-on-the-efficacy-of-cetuximab-plus/)
- [Pamidronate induces modifications of circulating angiogenetic factors in cancer patients.](https://scholariq.org/papers/pamidronate-induces-modifications-of-circulating-angiogenetic-factors-in-cancer/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Sarcoma Diagnosis and Treatment](https://scholariq.org/topics/sarcoma-diagnosis-and-treatment/)
- [Colorectal Cancer Treatments and Studies](https://scholariq.org/topics/colorectal-cancer-treatments-and-studies/)
- [Bone health and treatments](https://scholariq.org/topics/bone-health-and-treatments/)
- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Researcher university

- [Università Campus Bio-Medico](https://scholariq.org/institutions/universita-campus-bio-medico/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.